ApconiX and PhysioStim will be celebrating their first year of The European Centre of Excellence for preclinical cardiovascular electrophysiology at the Safety Pharmacology Society Annual Meeting in Washington this September. ApconiX will be supporting PhysioStim as they exhibit at the Marriott Wardman Park Hotel on Stand 412 from the 30th of September to the 3rd October.
Come and say “hello” to Marie Le Grand, Richard Printemps and Mike Morton who will be very happy to answer your questions on preclinical cardiac safety studies, both in the GLP and non-GLP format.
In combining both company’s extensive expertise, The Centre offers a complete range of studies from screening to customised problem-solving. The service includes automated electrophysiology providing hERG screening and CiPA ion channel assays, GLP compliant assays: manual patch-clamp assays (hERG, hNav1.5, hCav1.2), action potential recordings, Langendorff models and cardiac contractility studies.
The Centre is designed to help companies make better decisions in selecting the optimal clinical lead candidates at an early stage. Additional to the ion channel screening and assay development, ApconiX provides expert nonclinical safety expertise to help put this data into context for each drug project.
From target review to regulatory approval, ApconiX helps organisations to assess, reduce and manage potential risk factors and bring safe, effective and profitable drugs to market.
Look forward to seeing you in Washington!